Octagon Capital Advisors LP 13D/13G Filings for AN2 Therapeutics, Inc. (ANTX)

Octagon Capital Advisors LP 13D and 13G filings for AN2 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-08-28
4:02 pm
Sale		 2024-08-26 13G AN2 Therapeutics, Inc.
ANTX		 Octagon Capital Advisors LP 0
0.000%		 -3,009,927decrease
(Position Closed)		 Filing
2024-07-03
08:02 am
Purchase		 2024-06-13 13G AN2 Therapeutics, Inc.
ANTX		 Octagon Capital Advisors LP 3,009,927
10.100%		 3,009,927increase
(New Position)		 Filing